Abexol + Prevenox in Osteoarthritis

Phase 4

• Conditions: Osteoarthritis

• Registration Number: RPCEC00000171
• Lead Sponsor: Center of Natural Product / National Center for Scientific Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-09-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

The sample will be made ??up of:
1. Women and men.
2. Ages between 20 and 80 years.
3. With symptoms of OA (joint pain in hip, spine, limbs and / or phalanges).
4. Which have agreed to give informed consent.
5. Patients classified in Scales I-III of the American Association of Rheumatology.
6. Patients with WOMAC score = 25.

Exclusion Criteria

1. Existence of other forms of arthritis.
2. Arthroplasty in the last 3 years.
3. Any orthopedic surgery in the last 3 years.
4. Transplanted.
5. Active liver or kidney diseases.
6. Neoplasms diagnosed.
7. Severe high blood pressure
8. Uncompensated diabetes mellitus (fasting glucose> 7 mmol / L).
9. Hospitalization for any cause in the previous 6 months.
11. Subjects with normal clinical history of allergy to any other medicines
12. Subjects with other special conditions that endanger their health and their lives during the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Health Status (WOMAC questionnaire 0-Best Score between health status and 96-worst health status). Measuring Time: Before starting treatment and at the end of the 1st, 2nd, 3rd, 4th, 5th and 6th weeks